Mario C. Raviglione is the Director of the Global Tuberculosis Programme at the World Health Organization (WHO). He graduated from the University of Turin in Italy with a degree in medicine and surgery, and trained in internal medicine and infectious diseases, including AIDS, at the Cabrini Medical Centre in New York and Beth Israel Hospital at Harvard Medical School in Boston. At WHO, he managed the team that developed the Stop TB and End TB strategies in the context of the Millennium Development Goals and the Sustainable Development Goals, respectively. He was responsible for the development and implementation of the global TB and MDR-TB surveillance & monitoring system, and for setting norms, policies and standards on global TB care and control. He was the WHO focal point for the health agenda at the G8 Summit in Italy in 2010, and was responsible for World Health Day in 2011 on antimicrobial resistance. He is among the ten most cited authors worldwide in the field of TB with 35,000 citations and an h-index of 87. He has worked in over 50 countries and has served as a visiting professor and lecturer in various universities worldwide, including Johns Hopkins, Harvard, McGill, Sydney, Geneva, Pavia, Modena, Reggio Emilia, and Brescia. He serves as member of several important committees. He is among the top 20 Italian scientists in clinical sciences and has received various international awards for his work on TB and global health.